Prasad YR - Search Results

1

Endostatin in disease modulation: From cancer to beyond.

Anakha J, Prasad YR, Pande AH. Anakha J, et al. Among authors: prasad yr. Vascul Pharmacol. 2024 Dec 19;158:107459. doi: 10.1016/j.vph.2024.107459. Online ahead of print. Vascul Pharmacol. 2024. PMID: 39708990 Review.

2

Broad-spectrum anti-cancer activity of fused human arginase variants.

Prasad YR, Anakha J, Jawalekar SS, Pande AH. Prasad YR, et al. Invest New Drugs. 2024 Oct;42(5):531-537. doi: 10.1007/s10637-024-01466-8. Epub 2024 Aug 20. Invest New Drugs. 2024. PMID: 39160429

3

Treating liver cancer through arginine depletion.

Prasad YR, Anakha J, Pande AH. Prasad YR, et al. Drug Discov Today. 2024 Apr;29(4):103940. doi: 10.1016/j.drudis.2024.103940. Epub 2024 Mar 6. Drug Discov Today. 2024. PMID: 38452923 Review.

4

Human arginase I: a potential broad-spectrum anti-cancer agent.

Anakha J, Prasad YR, Sharma N, Pande AH. Anakha J, et al. Among authors: prasad yr. 3 Biotech. 2023 May;13(5):159. doi: 10.1007/s13205-023-03590-3. Epub 2023 May 3. 3 Biotech. 2023. PMID: 37152001 Free PMC article. Review.

5

Synthesis, Biological and Computational Evaluation of Novel 2,3-dihydro-2-aryl-4-(4- isobutylphenyl)-1,5-benzothiazepine Derivatives as Anticancer and Anti-EGFR Tyrosine Kinase Agents.

Shaik AB, Prasad YR, Nissankararao S, Shahanaaz S. Shaik AB, et al. Among authors: prasad yr. Anticancer Agents Med Chem. 2020;20(9):1115-1128. doi: 10.2174/1871520620666200130091142. Anticancer Agents Med Chem. 2020. PMID: 32000647

6

Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.

Lokesh BVS, Prasad YR, Shaik AB. Lokesh BVS, et al. Among authors: prasad yr. Infect Disord Drug Targets. 2019;19(3):310-321. doi: 10.2174/1871526519666181217120626. Infect Disord Drug Targets. 2019. PMID: 30556506

7

Part-1: Design, synthesis and biological evaluation of novel bromo-pyrimidine analogs as tyrosine kinase inhibitors.

Munikrishnappa CS, Puranik SB, Kumar GV, Prasad YR. Munikrishnappa CS, et al. Among authors: prasad yr. Eur J Med Chem. 2016 Aug 25;119:70-82. doi: 10.1016/j.ejmech.2016.04.056. Epub 2016 Apr 25. Eur J Med Chem. 2016. PMID: 27155464

8

3D QSAR analysis of 2-(substituted aryl)-thiazolidine-4-carboxamides as potent antitubercular agents.

Nagasree KP, Kumar MM, Prasad YR, Sriram D, Yogeeswari P. Nagasree KP, et al. Among authors: prasad yr. Curr Comput Aided Drug Des. 2014;10(3):274-81. doi: 10.2174/1573409910666141121100515. Curr Comput Aided Drug Des. 2014. PMID: 25413596

9

(2E)-3-(2-Bromo-phen-yl)-1-(5-bromo-thio-phen-2-yl)prop-2-en-1-one.

Vepuri SB, Devarajegowda HC, Jeyaseelan S, Anbazhagan S, Prasad YR. Vepuri SB, et al. Among authors: prasad yr. Acta Crystallogr Sect E Struct Rep Online. 2012 Dec 1;68(Pt 12):o3456. doi: 10.1107/S1600536812047939. Epub 2012 Nov 28. Acta Crystallogr Sect E Struct Rep Online. 2012. PMID: 23476268 Free PMC article.

10

A new diterpene from the leaves of Andrographis paniculata Nees.

Radhika P, Prasad YR, Sowjanya K. Radhika P, et al. Among authors: prasad yr. Nat Prod Commun. 2012 Apr;7(4):485-6. Nat Prod Commun. 2012. PMID: 22574448

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters